CompletedNot Applicable

The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns

South Korea48 participantsStarted 2020-04-15

Plain-language summary

In burn patients, the wound healing process may lead to a fibrotic hypertrophic scar, which is raised, inflexible and responsible functional impairments. There are few studies which have investigated the effect of extracorporeal shock wave therapy (ESWT) on hypertrophic scar characteristics using objective measurements. Thus, this study aimed to ascertain the effects of ESWT on burn scars using objective measurements. This double-blinded, randomized, controlled trial involved 36 patients with burns. Patients were randomized into a ESWT (an energy flux density (EFD) of 0.05 to 0.30 mJ/mm2, frequency of 4Hz, and 1000 to 2000 impulses) or a sham stimulation group.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged ≥18 years * deep partial-thickness (second-degree) burn or a full thickness (third-degree) burn * less than 6 months since the onset of the burn injury Exclusion Criteria: * history of cancer * fourth-degree burns (involving muscles, tendons, and bone injuries) * musculoskeletal diseases (fracture, amputation, rheumatoid arthritis, and degenerative joint diseases) * pregnancy * if there was potential for additional damage to the skin due to the use of ESWT and conventional occupational therapy

What they're measuring

scar thickness

Timeframe: 4 weeks

Trial details

NCT IDNCT04340271

SponsorHangang Sacred Heart Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-05-31

View on ClinicalTrials.gov More Burn Scar trials